SCHEMBL56556

SCHEMBL56556

CCc1ccc(O)c(O)c1

nearest known ligand 1.00 ✓ in ChEMBL — recovers established targets

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TRPA1 O75762 2/20 1.00
CA1 P00915 1/20 0.64
CA2 P00918 1/20 0.64
CA4 P22748 1/20 0.64
CA6 P23280 1/20 0.64
ALOX15 P16050 6/20 0.58
IGF1R P08069 2/20 0.58
HIF1A Q16665 5/20 0.58
HSD17B10 Q99714 5/20 0.58
KDM4E B2RXH2 4/20 0.58
ALDH1A1 P00352 4/20 0.58
TP53 P04637 4/20 0.58
MAPK1 P28482 4/20 0.58
MAPT P10636 4/20 0.58
ALOX12 P18054 3/20 0.58
RECQL P46063 3/20 0.58
CYP3A4 P08684 3/20 0.58
THPO P40225 3/20 0.58
CYP2D6 P10635 3/20 0.58
DRD2 P14416 3/20 0.58

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30290839 1.00 TRPA1 (1.00) TRPA1CA1CA2CA4CA6
Hydrochloric Acid SCHEMBL27628625 0.95 TRPA1 (0.91) TRPA1CA1CA2CA4CA6
Catechol SCHEMBL27772538 0.93 TRPA1 (0.86) TRPA1CA1CA2CA4CA6
Catechol SCHEMBL9474502 0.93 TRPA1 (0.86) TRPA1CA1CA2CA4CA6
Bicarbonate SCHEMBL8911264 0.91 TRPA1 (0.83) TRPA1CA1CA2CA4CA6
Sulfuric Acid SCHEMBL22717118 0.89 TRPA1 (0.79) TRPA1CA1CA2CA4CA6
Ethylbenzene SCHEMBL27772545 0.89 TRPA1 (0.79) TRPA1CA1CA2CA4CA6
Sulfuric Acid SCHEMBL29440275 0.89 TRPA1 (0.79) TRPA1CA1CA2CA4CA6
Pyrogallol SCHEMBL27793837 0.87 TRPA1 (0.76) TRPA1CA1CA2CA4CA6
SCHEMBL27772543 0.86 TRPA1 (0.75) TRPA1ALOX15IGF1RHIF1AHSD17B10

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1056 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4655410-A2 O-METHYLATION OF PHENOLIC SUBSTANCES VIA FUNGAL O-METHYLTRANSFERASE Symrise AG (DE) 2025-12-03 EP claimed
US-20250276107-A1 HYDROGEL SYSTEMS AND METHODS FOR TREATING FISTULA AND OTHER INDICATIONS TERASAKI INSTITUTE FOR BIOMEDICAL INNOVATION (US) 2025-09-04 US claimed
US-20250237947-A1 Dry Film Resist, Photosensitive Dry Film, and Copper Clad Laminate HANGZHOU FIRST ELECTRONIC MATERIAL CO., LTD (CN) 2025-07-24 US claimed
US-20250093319-A1 DETECTING WINE CHARACTERISTICS FROM WINE SAMPLES FENG YE (US) 2025-03-20 US claimed
CN-116216905-B Composition for selectively degrading aniline pollutants as well as preparation method and application thereof 中山大学 2025-03-04 CN claimed
CN-119395945-A Photosensitive resin composition, photosensitive element, method for producing wiring board, and photosensitive element roll 株式会社力森诺科 2025-02-07 CN claimed
CN-119148465-A Photosensitive resin composition, photosensitive dry film and application thereof 杭州福斯特电子材料有限公司 2024-12-17 CN claimed
CN-113557474-B Photosensitive resin composition, photosensitive element, method for producing wiring board, and photosensitive element roll 株式会社力森诺科 2024-12-13 CN claimed
US-12163004-B2 Polymer composites WARNER BABCOCK INSTITUTE FOR GREEN CHEMISTRY, LLC (US) 2024-12-10 US claimed
US-20240368505-A1 FLUORINE-FREE CLEANING AGENT, PREPARATION METHOD THEREFOR AND USE THEREOF Tan Kah Kee Innovation Laboratory (CN) 2024-11-07 US claimed
WO-2008154083-A2 COMPOUNDS, COMPOSITIONS AND METHODS FOR THE TREATMENT OF SYNUCLEINOPATHIES PROTEO TECH INC. (US) 2008-12-18 WO claimed
EP-1511710-A1 COMPOUNDS, COMPOSITIONS AND METHODS FOR THE TREATMENT OF AMYLOID DISEASES AND SYNUCLEINOPATHIES SUCH AS ALZHEIMER S DISEASE, TYPE 2 DIABETES, AND PARKINSON S DISEASE Proteotech, Inc. (US) 2005-03-09 EP claimed
WO-2003101927-A1 COMPOUNDS, COMPOSITIONS AND METHODS FOR THE TREATMENT OF AMYLOID DISEASES AND SYNUCLEINOPATHIES SUCH AS ALZHEIMER'S DISEASE, TYPE 2 DIABETES, AND PARKINSON'S DISEASE PROTEOTECH, INC. (US) 2003-12-11 WO claimed
EP-0390102-A2 Process for the preparation of pyridine-2,3-dicarboxylic acids CELGENE CORPORATION (US) 1990-10-03 EP claimed
EP-0376724-A2 Cephalosporin compounds TANABE SEIYAKU CO., LTD. (JP) 1990-07-04 EP claimed
US-4894139-A Methods for deactivating copper in hydrocarbon fluids BETZ LABORATORIES, INC. (US) 1990-01-16 US claimed
US-4802972-A BY HYDROGEN CONTAINING GAS AND A CATALYST COMPRISING CATECHOL COMPOUND OF MOLYBDENUM PHILLIPS PETROLEUM COMPANY (US) 1989-02-07 US claimed
US-4196112-A ADDUCT OF A BUTADIENE POLYMER AN A,B-ACID, A CARBOCYCLIC ALCOHOL GELATION INHIBITOR, A HYDROPHILIC SOLVENT, A NEUTRALIZER NIPPON OIL CO., LTD. (JP) 1980-04-01 US claimed
US-4175068-A ADDUCT OF BUTADIENE AND UNSATURATED DICARBOXYLIC ACID, NEUTRALIZER NIPPON OIL CO., LTD. (JP) 1979-11-20 US claimed
US-3979390-A Butyrophenone derivatives and production thereof SUMITOMO CHEMICAL COMPANY, LIMITED (JA) 1976-09-07 US claimed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20250237947-A1 Dry Film Resist, Photosensitive Dry Film, and Copper Clad Laminate PADI2, PADI4, PADI1 TRPA1 239/4885CA1 777/4885CA2 873/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.